STAT+: Pharmalittle: We’re reading about an FDA gender rule change, its program for one-day inspections, and more
An FDA proposal to remove references to “gender” from its regulations sparked concerns about unintended consequences on research
Original Source
Read the full article at Statnews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.